# SGCD

## Overview
The SGCD gene encodes the delta-sarcoglycan protein, a transmembrane component of the sarcoglycan complex, which is integral to the dystrophin-glycoprotein complex (DGC) in muscle cells. Delta-sarcoglycan plays a critical role in maintaining the structural integrity of muscle cell membranes by linking the cytoskeleton to the extracellular matrix, thereby stabilizing the membrane during muscle contraction. This protein is essential for the proper assembly and function of the sarcoglycan complex, which is crucial for muscle cell stability and function. Mutations in the SGCD gene can lead to muscular dystrophies, such as limb-girdle muscular dystrophy type 2F (LGMD2F), and cardiac conditions like dilated cardiomyopathy (DCM), underscoring its importance in muscle and cardiac health (Brunetti2023SGCD; Vainzof2021Sarcoglycanopathies:).

## Structure
The human SGCD gene encodes the δ-sarcoglycan protein, which is a component of the sarcoglycan complex, part of the dystrophin-glycoprotein complex in muscle cells. The primary structure of δ-sarcoglycan consists of 290 amino acids, showing high conservation with the porcine and murine δ-sarcoglycan, which have 289 amino acids (Matsunari2020Pigs). The protein is predicted to have a single transmembrane domain, typical of sarcoglycans, which allows it to span the muscle cell membrane.

The secondary structure likely includes alpha helices and beta sheets, common in transmembrane proteins, although specific details are not provided in the context. The tertiary structure involves the 3D folding necessary for its function in the sarcoglycan complex. In terms of quaternary structure, δ-sarcoglycan assembles with other sarcoglycans (α, β, and γ) to form a heterotetramer, which is crucial for linking the muscle cytoskeleton to the extracellular matrix (Smith2022Novel).

Post-translational modifications such as glycosylation may occur, which are typical for proteins involved in cell membrane stability and signaling. The human SGCD gene has three splice variants, which may result in different isoforms of the δ-sarcoglycan protein, although specific functional differences are not detailed in the context (Matsunari2020Pigs).

## Function
The SGCD gene encodes delta-sarcoglycan, a crucial component of the sarcoglycan complex, which is part of the larger dystrophin-associated protein complex (DAPC) in muscle cells. This complex plays a vital role in maintaining the integrity of the muscle cell membrane by linking the actin cytoskeleton to the extracellular matrix, thereby stabilizing the membrane during muscle contraction and protecting it from damage (Shi2004Specific). Delta-sarcoglycan, along with other sarcoglycan isoforms, forms a core structure essential for the proper assembly and localization of the sarcoglycan complex to the plasma membrane (Shi2004Specific). 

In healthy cells, delta-sarcoglycan is involved in intracellular signal transduction and may play a role in mediating the effects of biglycan, a protein involved in muscle regeneration and myogenesis (Constantin2014Dystrophin). The proper assembly of the sarcoglycan complex, facilitated by delta-sarcoglycan, is crucial for muscle function, as it ensures the stability and function of the muscle cell membrane (Shi2004Specific). Dysfunction or absence of delta-sarcoglycan can lead to muscular dystrophies, highlighting its critical role in maintaining muscle cell stability and function (Constantin2014Dystrophin).

## Clinical Significance
Mutations in the SGCD gene, which encodes δ-sarcoglycan, are associated with several muscular and cardiac conditions. One of the primary diseases linked to SGCD mutations is limb-girdle muscular dystrophy type 2F (LGMD2F), characterized by progressive muscle weakness and wasting. This condition is typically inherited in an autosomal recessive manner, although some mutations can lead to dominant negative effects (Brunetti2023SGCD; Younus2019SGCD).

SGCD mutations are also implicated in dilated cardiomyopathy (DCM), a condition that affects the heart's ability to pump blood efficiently. DCM can occur with or without skeletal muscle involvement, depending on the specific mutation. Some mutations, such as p.S151A and c.K238, are associated with severe forms of DCM, often inherited in an autosomal dominant pattern (S2000Mutations; Chen2015A).

In addition to muscular and cardiac conditions, SGCD has been linked to age-related macular degeneration (AMD), particularly the geographic atrophy phenotype. Certain polymorphisms in SGCD are associated with increased risk of AMD, suggesting a potential role in retinal function (PerezOrtiz2018Significant). The phenotypic expression of SGCD mutations can vary, influenced by factors such as modifier genes or compensatory mechanisms (Bauer2009Does).

## Interactions
The SGCD gene encodes the δ-sarcoglycan protein, which is a component of the sarcoglycan subcomplex within the dystrophin-glycoprotein complex (DGC) in muscle cells. This complex is essential for linking the cytoskeleton of muscle fibers to the extracellular matrix, providing structural support during muscle contraction (Vainzof2021Sarcoglycanopathies:). δ-Sarcoglycan interacts with other sarcoglycans, including α-, β-, and γ-sarcoglycan, to form a stable transmembrane complex. This interaction is crucial for maintaining the integrity of the sarcolemma, the outer membrane of muscle cells (S2000Mutations).

Mutations in the SGCD gene can disrupt these interactions, leading to deficiencies in the sarcoglycan complex and secondary deficiencies in the DGC, which can result in muscular dystrophies such as limb-girdle muscular dystrophy (LGMD) and dilated cardiomyopathy (DCM) (S2000Mutations; Vainzof2021Sarcoglycanopathies:). The absence of δ-sarcoglycan can lead to the loss of other sarcoglycans from the plasma membrane, destabilizing the sarcolemmal integrity and causing contraction-induced cell damage (Rutschow2013S151A). This highlights the critical role of δ-sarcoglycan in the assembly and function of the sarcoglycan complex.


## References


[1. (Brunetti2023SGCD) Barbara Brunetti, Barbara Bacci, Jessica Maria Abbate, Giorgia Tura, Orlando Paciello, Emanuela Vaccaro, Francesco Prisco, Gualtiero Gandini, Samuel Okonji, Andrea di Paola, Anna Letko, Cord Drögemüller, Vidhya Jagannathan, Maria Elena Turba, Tolulope Grace Ogundipe, Luca Lorenzini, Marco Rosati, Dimitra Psalla, Tosso Leeb, and Michaela Drögemüller. Sgcd missense variant in a lagotto romagnolo dog with autosomal recessively inherited limb-girdle muscular dystrophy. Genes, 14(8):1641, August 2023. URL: http://dx.doi.org/10.3390/genes14081641, doi:10.3390/genes14081641. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14081641)

[2. (Vainzof2021Sarcoglycanopathies:) Mariz Vainzof, Lucas S. Souza, Juliana Gurgel-Giannetti, and Mayana Zatz. Sarcoglycanopathies: an update. Neuromuscular Disorders, 31(10):1021–1027, October 2021. URL: http://dx.doi.org/10.1016/j.nmd.2021.07.014, doi:10.1016/j.nmd.2021.07.014. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.nmd.2021.07.014)

[3. (Shi2004Specific) Weixing Shi, Zaili Chen, Jodi Schottenfeld, Richard C. Stahl, Louis M. Kunkel, and Yiu‐Mo Chan. Specific assembly pathway of sarcoglycans is dependent on beta‐ and delta‐sarcoglycan. Muscle &amp; Nerve, 29(3):409–419, February 2004. URL: http://dx.doi.org/10.1002/mus.10566, doi:10.1002/mus.10566. This article has 47 citations.](https://doi.org/10.1002/mus.10566)

[4. (Bauer2009Does) Ralf Bauer, Judith Hudson, Harald D Müller, Clemens Sommer, Gabriele Dekomien, John Bourke, Daniel Routledge, Kate Bushby, Jörg Klepper, and Volker Straub. Does δ-sarcoglycan-associated autosomal-dominant cardiomyopathy exist? European Journal of Human Genetics, 17(9):1148–1153, March 2009. URL: http://dx.doi.org/10.1038/ejhg.2009.17, doi:10.1038/ejhg.2009.17. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2009.17)

[5. (S2000Mutations) Tsubata S, Bowles KR, Vatta M, Zintz C, Bowles NE, and Towbin JA. Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy, a disease of the cytoskeleton and sarcolemma. Circulation, 102(21):2672–2672, November 2000. URL: http://dx.doi.org/10.1161/01.cir.102.21.2672-j, doi:10.1161/01.cir.102.21.2672-j. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/01.cir.102.21.2672-j)

[6. (Matsunari2020Pigs) Hitomi Matsunari, Michiyo Honda, Masahito Watanabe, Satsuki Fukushima, Kouta Suzuki, Shigeru Miyagawa, Kazuaki Nakano, Kazuhiro Umeyama, Ayuko Uchikura, Kazutoshi Okamoto, Masaki Nagaya, Teruhiko Toyo-oka, Yoshiki Sawa, and Hiroshi Nagashima. Pigs with δ-sarcoglycan deficiency exhibit traits of genetic cardiomyopathy. Laboratory Investigation, 100(6):887–899, June 2020. URL: http://dx.doi.org/10.1038/s41374-020-0406-7, doi:10.1038/s41374-020-0406-7. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41374-020-0406-7)

[7. (Smith2022Novel) Tara C. Smith, Georgios Vasilakos, Scott A. Shaffer, Jason M. Puglise, Chih-Hsuan Chou, Elisabeth R. Barton, and Elizabeth J. Luna. Novel γ-sarcoglycan interactors in murine muscle membranes. Skeletal Muscle, January 2022. URL: http://dx.doi.org/10.1186/s13395-021-00285-2, doi:10.1186/s13395-021-00285-2. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13395-021-00285-2)

[8. (Constantin2014Dystrophin) Bruno Constantin. Dystrophin complex functions as a scaffold for signalling proteins. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1838(2):635–642, February 2014. URL: http://dx.doi.org/10.1016/j.bbamem.2013.08.023, doi:10.1016/j.bbamem.2013.08.023. This article has 150 citations.](https://doi.org/10.1016/j.bbamem.2013.08.023)

[9. (Chen2015A) Jie Chen, Ye Jin, Hong Wang, Sisi Wei, Dan Chen, Li Ying, Qing Zhou, Gang Li, Joyce Li, Jimin Gao, Naoya Kato, Wei Hu, Yigang Li, and Yuepeng Wang. A haplotype of two novel polymorphisms in δ-sarcoglycan gene increases risk of dilated cardiomyopathy in mongoloid population. PLOS ONE, 10(12):e0145602, December 2015. URL: http://dx.doi.org/10.1371/journal.pone.0145602, doi:10.1371/journal.pone.0145602. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0145602)

[10. (Rutschow2013S151A) Désirée Rutschow, Ralf Bauer, Caroline Göhringer, Raffi Bekeredjian, Stefanie Schinkel, Volker Straub, Michael Koenen, Dieter Weichenhan, Hugo A Katus, and Oliver J Müller. S151a δ-sarcoglycan mutation causes a mild phenotype of cardiomyopathy in mice. European Journal of Human Genetics, 22(1):119–125, May 2013. URL: http://dx.doi.org/10.1038/ejhg.2013.97, doi:10.1038/ejhg.2013.97. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2013.97)

[11. (Younus2019SGCD) Muhammad Younus, Farooq Ahmad, Erum Malik, Muhammad Bilal, Mehran Kausar, Safdar Abbas, Shabnam Shaheen, Mohib Ullah Kakar, Majid Alfadhel, and Muhammad Umair. Sgcd homozygous nonsense mutation (p.arg97∗) causing limb-girdle muscular dystrophy type 2f (lgmd2f) in a consanguineous family, a case report. Frontiers in Genetics, January 2019. URL: http://dx.doi.org/10.3389/fgene.2018.00727, doi:10.3389/fgene.2018.00727. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2018.00727)

[12. (PerezOrtiz2018Significant) Andric Christopher Perez-Ortiz, Alexandra Luna-Angulo, Juan Carlos Zenteno, Alvaro Rendon, Liliana Guadalupe Cortes-Ballinas, David Jimenez-Collado, Bani Antonio-Aguirre, Martha Janneth Peralta-Ildefonso, Israel Ramírez, Stefany Jacob-Kuttothara, and Francisco Javier Estrada-Mena. Significant association between variant in sgcd and age-related macular degeneration. Genes, 9(10):467, September 2018. URL: http://dx.doi.org/10.3390/genes9100467, doi:10.3390/genes9100467. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes9100467)